Rob Verger, assistant tech editor at Popular Science, discusses SpaceX's successful launch of the Falcon Heavy rocket that propelled Elon Musk's red Tesla Roadster into orbit. The release of the car into space has prompted people to ask the question, "what now?"
Verger notes that it will take two and a half years for the rocket to orbit around the sun and end up back where it started from. It will be another five years before we could potentially see it with a telescope.
Verger says the Roadster will face significant deterioration due to radiation and a "sandblasting" of dust that will cause the car to lose its cherry red color. He talks about the vastness of space, noting it's unlikely the car would be destroyed by an asteroid.
Melissa Whitely, personal trainer for Life Time Fitness, spoke with Cheddar News about the importance of recovery following a tense workout session. "If we're not going through the proper recovery methods, we can have undue pain, discomfort, tightness in our muscles and all those other things we can avoid," she said.
Dr. Payel Gupta, medical director of allergy, asthma, immunology & ENT for LifeMD.com, joined Cheddar News to discuss some tips on how to cope with allergy season. "With the warmer temperatures, we're seeing that the seasons arrive sooner and actually last longer, and also the elevated CO2 levels actually cause the plants to release more pollen," she said.
A new survey from the National Council for Mental Wellbeing shows that four in five behavioral health workers were concerned that labor shortages in their field “negatively impact society as a whole.”
Food and Drug Administration regulators on Tuesday approved a first-of-a-kind drug for a rare form of Lou Gehrig’s disease, though they are requiring further research to confirm it truly helps patients.
A Japanese company's attempt to land a spacecraft on the moon has apparently failed. Flight controllers lost contact Wednesday with the lander after it descended from lunar orbit, aiming for the dusty surface.
The Supreme Court on Friday preserved women’s access to a drug used in the most common method of abortion, rejecting lower-court restrictions while a lawsuit continues.
